These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24077804)

  • 21. 5'UTR polymorphism in the serotonergic receptor HTR3A gene is differently associated with striatal Dopamine D2/D3 receptor availability in the right putamen in Fibromyalgia patients and healthy controls-Preliminary evidence.
    Ledermann K; Hasler G; Jenewein J; Sprott H; Schnyder U; Martin-Soelch C
    Synapse; 2020 May; 74(5):e22147. PubMed ID: 31868947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Acute and Chronic Treatments with Dopamine D
    Thomsen M; Barrett AC; Butler P; Negus SS; Caine SB
    J Pharmacol Exp Ther; 2017 Jul; 362(1):161-176. PubMed ID: 28473458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of eticlopride and the selective D3-antagonist PNU 99194-A on food- and cocaine-maintained responding in rhesus monkeys.
    Claytor R; Lile JA; Nader MA
    Pharmacol Biochem Behav; 2006 Mar; 83(3):456-64. PubMed ID: 16631246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic Δ
    John WS; Martin TJ; Solingapuram Sai KK; Nader SH; Gage HD; Mintz A; Nader MA
    J Pharmacol Exp Ther; 2018 Feb; 364(2):300-310. PubMed ID: 29203575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between subcortical brain volume and striatal dopamine D
    Caravaggio F; Ku Chung J; Plitman E; Boileau I; Gerretsen P; Kim J; Iwata Y; Patel R; Chakravarty MM; Remington G; Graff-Guerrero A
    Hum Brain Mapp; 2017 Nov; 38(11):5519-5534. PubMed ID: 28752565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).
    Vernaleken I; Fellows C; Janouschek H; Bröcheler A; Veselinovic T; Landvogt C; Boy C; Buchholz HG; Spreckelmeyer K; Bartenstein P; Cumming P; Hiemke C; Rösch F; Schäfer W; Wong DF; Gründer G
    J Clin Psychopharmacol; 2008 Dec; 28(6):608-17. PubMed ID: 19011428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in D2 dopamine receptor availability and reaction to novelty in socially housed male monkeys during abstinence from cocaine.
    Czoty PW; Gage HD; Nader MA
    Psychopharmacology (Berl); 2010 Mar; 208(4):585-92. PubMed ID: 20066401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine receptor agonist- and antagonist-induced behaviors in primates previously treated with dopamine receptor antagonists: the pathogenetic mechanisms of acute oral dyskinesia.
    Lublin H
    Clin Neuropharmacol; 1995 Dec; 18(6):533-51. PubMed ID: 8681313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic treatment with extended release methylphenidate does not alter dopamine systems or increase vulnerability for cocaine self-administration: a study in nonhuman primates.
    Gill KE; Pierre PJ; Daunais J; Bennett AJ; Martelle S; Gage HD; Swanson JM; Nader MA; Porrino LJ
    Neuropsychopharmacology; 2012 Nov; 37(12):2555-65. PubMed ID: 22805600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of antidepressant drugs on the dopamine D2/D3 receptors in the rat brain differentiated by agonist and antagonist binding--an autoradiographic analysis.
    Rogoz R; Dziedzicka-Wasylewska M
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):178-86. PubMed ID: 10208304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The distribution of D2/D3 receptor binding in the adolescent rhesus monkey using small animal PET imaging.
    Christian BT; Vandehey NT; Fox AS; Murali D; Oakes TR; Converse AK; Nickles RJ; Shelton SE; Davidson RJ; Kalin NH
    Neuroimage; 2009 Feb; 44(4):1334-44. PubMed ID: 19015034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of dopamine D2 receptor partial agonist antipsychotic aripiprazole on dopamine synthesis in human brain measured by PET with L-[β-11C]DOPA.
    Ito H; Takano H; Arakawa R; Takahashi H; Kodaka F; Takahata K; Nogami T; Suzuki M; Suhara T
    PLoS One; 2012; 7(9):e46488. PubMed ID: 23029533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.
    Boileau I; Payer D; Chugani B; Lobo D; Behzadi A; Rusjan PM; Houle S; Wilson AA; Warsh J; Kish SJ; Zack M
    Addiction; 2013 May; 108(5):953-63. PubMed ID: 23167711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of 50-kHz ultrasonic vocalizations by dopamine receptor subtype-selective agonists and antagonists in adult rats.
    Scardochio T; Clarke PB
    Psychopharmacology (Berl); 2013 Apr; 226(3):589-600. PubMed ID: 23192317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the reinforcing efficacy of two dopamine D2-like receptor agonists in rhesus monkeys using a progressive-ratio schedule of reinforcement.
    Woolverton WL; Ranaldi R
    Pharmacol Biochem Behav; 2002 Jul; 72(4):803-9. PubMed ID: 12062569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys.
    Platt DM; Rodefer JS; Rowlett JK; Spealman RD
    Psychopharmacology (Berl); 2003 Mar; 166(3):298-305. PubMed ID: 12589523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A positron emission tomography (PET) investigation of the role of striatal dopamine (D2) receptor availability in spatial cognition.
    Reeves SJ; Grasby PM; Howard RJ; Bantick RA; Asselin MC; Mehta MA
    Neuroimage; 2005 Oct; 28(1):216-26. PubMed ID: 15979345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Striatal and extrastriatal dopamine D₂ receptor occupancy by the partial agonist antipsychotic drug aripiprazole in the human brain: a positron emission tomography study with [¹¹C]raclopride and [¹¹C]FLB457.
    Takahata K; Ito H; Takano H; Arakawa R; Fujiwara H; Kimura Y; Kodaka F; Sasaki T; Nogami T; Suzuki M; Nagashima T; Shimada H; Kato M; Mimura M; Suhara T
    Psychopharmacology (Berl); 2012 Jul; 222(1):165-72. PubMed ID: 22237854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.